Come along to Rüdiger Kaspera's Learning Lab at ASCPT, where he’ll dive into science and risk based strategies for designing oligonucleotide First‑in‑Human studies - covering toxicity, study design, PK/PD, population se...
ICON supports Rare Disease Day
Learn moreBuilding a comparative evidence base using network meta-analysis
Methods, implementation and reporting
Read the whitepaperFrom bottlenecks to breakthroughs
Human-centred strategies for faster study starts
Read the whitepaperOptimising vaccine follow-up through early planning
A proactive approach to RWD and tokenisation integration
Read the whitepaper
Featured solutions
EngageAI
Our voice of the customer feedback platform has been enhanced using AI; transforming how we listen, respond, and act on your feedback.
Blended solutions
Bespoke, seamless solutions to meet unique sponsor challenges.
Outcome Measures
A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients.
Biotech
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
Cardiac Safety Solutions
End-to-end cardiac safety solutions, including ECG, event monitoring, BPM, long-term Holter monitoring, ECHO and MUGA studies.
Early Clinical and Bioanalytical Solutions
Innovative early clinical solutions that will advance your drug development strategy.
Site & Patient Solutions
Transforming recruitment through patient-centric trials and real-world, real-time data.
Market Access
Expertise in mission-critical pricing, market access, and reimbursement.
Specialty Laboratory Solutions
Supporting precision medicine programs across all phases of drug diagnostic co-development.
Videos
ICON overview
ICON is expanding the possibilities of clinical research for customers, partners, and patients.
Biotech
Developing transformative therapies with small & mid-sized biopharma companies requires a flexible approach.
Technology solutions
ICON’s technology solutions are focused on the factors most critical to our customers.
AI @ICON
ICON is harnessing AI with pragmatic, impactful, award winning solutions for a healthier world.
Obesity
ICON has the cross functional expertise to help sponsors overcome the challenges associated with obesity research.
Webinars
Best practices in global flow cytometry quality control and harmonisation
5 March 2026. Register today.
When patients lead: Breaking barriers in ultra-rare disease drug development
3 March 2026. Register today.
Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases
Watch the webinar.
